pCMV-rox-STOP-rox-LifeAct-mCherry
(Plasmid
#261896)
-
PurposeDre-dependent F-actin reporter.Used for in utero electroporation to label F-actin in cortical neurons.
-
Depositing Lab
-
Depositing OrganizationDeutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)
Located in Germany -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 261896 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepEGFP-N1
-
Backbone manufacturerClontech/Takara
- Backbone size w/o insert (bp) 4898
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameLifeAct
-
Alt nameLifeAct-mCherry
-
SpeciesSynthetic
-
MutationNone
- Promoter CMV
-
Tag
/ Fusion Protein
- mCherry (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
rox-flanked STOP cassette (RSR) upstream of the F-actin-binding peptide Lifeact fused to mCherry, so expression occurs only after Dre recombination.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCMV-rox-STOP-rox-LifeAct-mCherry was a gift from Frank Bradke (Addgene plasmid # 261896 ; http://n2t.net/addgene:261896 ; RRID:Addgene_261896) -
For your References section:
An intrinsic cytoskeletal oscillator establishes neuronal polarity. Lin TC, Coles CH, Alfadil E, Fassler F, Husch A, Dupraz S, Pietralla T, Narita A, Schelski M, Flynn KC, Stern S, Mohl C, Hilton BJ, Vauti F, Arnold HH, Schur FKM, Bradke F. Nature. 2026 Jul 8. doi: 10.1038/s41586-026-10755-6. 10.1038/s41586-026-10755-6 PubMed 42420447